TYHC INTERNATIONAL PTE. LTD. – Trademark Portfolio
Entity Type: 03
TYHC INTERNATIONAL PTE. LTD. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include ACCUSOL. The owner is based in SINGAPORE.
3 TEMASEK AVENUE
#27-02 CENTENNIAL TOWER
SINGAPORE 039190 , SG
Showing of trademarks Trademarks
Trademark Classifications
TYHC INTERNATIONAL PTE. LTD.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does TYHC INTERNATIONAL PTE. LTD. have?
TYHC INTERNATIONAL PTE. LTD. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 abandoned.
What trademark classes does TYHC INTERNATIONAL PTE. LTD. file in?
TYHC INTERNATIONAL PTE. LTD. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are TYHC INTERNATIONAL PTE. LTD.'s most well-known trademarks?
TYHC INTERNATIONAL PTE. LTD.'s registered trademark portfolio includes well-known marks such as ACCUSOL. These are among 1 currently registered trademark in the portfolio.
What is TYHC INTERNATIONAL PTE. LTD.'s trademark registration success rate?
TYHC INTERNATIONAL PTE. LTD. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.